Call for Abstract
International Conference on Nanomedicine and Drug Delivery, will be organized around the theme “Applications of nanotehnology in recent COVID-19 treatment”
Nanomedicine Meet 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Nanomedicine Meet 2020
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Nanomedicine is simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behaviour of drug substances. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. The nanomedicines that are currently available are overcoming some of the difficulties experienced by normal medical approaches in delivering the benefit from the drug molecules used. In some cases the drugs have very little solubility in water and the human body struggles to absorb enough to treat the condition. In other cases, the drug molecule is absorbed well but the body removes the drug before it has had long enough to provide a benefit. Drugs may lead to side-effects due to poor delivery at the actual site of disease. For example, drugs that are targeting cancers must avoid healthy tissues and organs or damage can be caused. Nanomedicines therefore can play an important role in ensuring enough of the drug enters the body, that drug that does enter stays in the body for long periods and is targeted specifically to the areas that need treatment.
- Track 1-1 Bio inspired materials and drug delivery
- Track 1-2Nanocarriers
- Track 1-3Nano pharmaceutical industry overview
- Track 1-4Neurodegenerative Disorders
Nano toxicology is the study of the toxicity of nanomaterials. Because of quantum size effects and large surface area to volume ratio, nanomaterials have unique properties compared with their larger counterparts that affect their toxicity. Of the possible dangers, inhalation exposure appears to present the most concern, with animal studies showing pulmonary effects such as inflammation, fibrosis, and carcinogenicity for some nanomaterials. Skin contact and ingestion exposure are also a concern.
- Track 2-1Neonatal toxicity
- Track 2-2Mitochondrial injuries
- Track 2-3Cytotoxicity
- Track 2-4Toxicity to human lymphocytes
DNA nanotechnology is the design and manufacture of artificial nucleic acid structures for technical uses. In this field, nucleic acids are used as non-biological engineering materials for nanotechnology rather than as the carriers of genetic information in living cells. Researchers in the field have created static structures such as two- and three-dimensional crystal lattices, nanotubes, polyhedral, and arbitrary shapes, and functional devices such as molecular machines and DNA computers. The field is beginning to be used as a tool to solve basic science problems in structural biology and biophysics, including applications in X-ray crystallography and nuclear magnetic resonance spectroscopy of proteins to determine structures. Potential applications in molecular scale electronics and Nano medicine are also being investigated.
- Track 3-1Characterization of Pharmaceutical Nano tools
- Track 3-2Engineering of Pharmaceutical Nanosystems
- Track 3-3Applications of Pharmaceutical Nano tools
- Track 3-4Challenges to Pharmaceutical Nanotechnology
According to the World Health Organization (WHO), there will be 15 million new cases of cancer worldwide in 2020. More than 90% of cancer-related deaths occur by the spread of malignant cells to vital organs, a process called metastasis. Academia, Pharmaceutical and biotechnology companies are making substantial research investments in order to develop specific treatments that can destroy primary and secondary tumors, i.e. those resulting from metastasis to other organs. Nanotechnology in cancer treatments is already a reality providing a wide range of new tools and possibilities, from earlier diagnostics and improved imaging to better, more efficient, and more targeted therapies.
- Track 4-1Detection & Diagnosis
- Track 4-2Treatment & Therapy
- Track 4-3Safety of Nanotechnology
Nano Pharmaceutical Market report focuses on the major drivers and restraints for the key players. It also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Nano Pharmaceutical Market research report is a professional and in-depth study on the current state of the Nano Pharmaceutical Industry.
Nanomedicine is a field that incorporates the studies related to Nano sized particles, their function and behavior with respect to different systems. The tremendous capabilities of nanoparticles have changed the perspective and scope of nanotechnology towards development into an adjuvant field for the remaining fields of life sciences. The role of nanotechnology in the field of pharmaceutics has tremendously changed the way of our understanding about drugs, Nano drugs or the use of nanoparticles as carrier of drug has become the basic fundamental or criteria for the production or design of a drug and advances in nanotechnology.
Nanotechnology is an important field of modern research dealing with design, synthesis, and manipulation of particle structures ranging from approximately 1-100 nm.
The session Design of Nanomedicine and Nanotechnology includes broad topics like: Carbon Nanotubes, Nanoparticles, Gold Nanoparticles, Silver Nanoparticles, Magnetic Nanoparticles, Nano Micro Particles, Nanocomposite Microspheres, Biosensors and Nano bioelectronics, Bio inspired materials and drug delivery and Nanobiomechanics and Nanomedicine.
- Track 6-1Inorganic Nanoparticles
- Track 6-2Nanochemistry
- Track 6-3Future Scope and Prospects of Pharmaceutical Nanotechnology
- Track 6-4Regenerative Medicine
- Track 6-5Nanocarriers for CNS Drug Delivery
To reach target cell, designing of Nano drugs are major aspects, where researcher interested or developing novel Nano drugs. Aimed and specially designed session for researchers developing Nano drugs for delivery of amino acids, Nucleic acids and proteins. The session Design of Nanodrugs includes: Novel Drugs to Nano drugs, Nano drugs for Cancer Therapy, Nano drugs for Veterinary Therapeutics, Nano drugs for Medical applications and Nano drugs for Herbal medicines and Cosmetics. Apart from Nano drugs, nanotechnology also aided in the development of therapeutics at the genetic level, wherein gene delivery methods are employed to attain a more precise therapeutic approach.
- Track 7-1Implantable materials and surgical technologies
- Track 7-2Inorganic Nanoparticles
- Track 7-3Applications of Pharmaceutical Nano tools
Nanotechnology mediated Tissue engineering is a branch a branch of biomedical engineering, which aims at the application of nanotechnology in tissue engineering mediated therapeutic techniques. Tissue engineering and regenerative medicine are concerned with the replacement or regeneration of cells, tissues (the focus of tissue engineers) or organs to restore normal biological function.
- Track 8-1 Biological scaffolds
- Track 8-2Biomaterials
- Track 8-33Structure function relationship
- Track 8-4Biomarkers
Nano pharmaceuticals deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signaling and activity. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.
- Track 9-1Nanosuspension
- Track 9-2Nanocarriers
- Track 9-3Nano engineered drugs
- Track 9-4Advantages of nanopharmaceuticals
Theranostic nanomedicine is emerging as a promising therapeutic paradigm. It takes advantage of the high capacity of Nano platforms to ferry cargo and loads onto them both imaging and therapeutic functions. The resulting Nano systems, capable of diagnosis, drug delivery and monitoring of therapeutic response, are expected to play a significant role in the dawning era of personalized medicine, and much research effort has been devoted toward that goal.
- Track 10-1Nanorobotic applications in medicine
- Track 10-2Explicit and Revolutionary of Nanomedicine
- Track 10-3Nanotechnology in Nanomedicine
- Track 10-4Development and Application of Ever-Improving Nanotools
- Track 10-5Evolutionary of Nanomedicine
As the science and technology of nanomedicine speed ahead, ethics, policy, and the law struggle to catch up also chases after it. It is important to proactively address the ethical, social and regulatory aspects of nanomedicine to minimize its adverse impacts on the environment and public health and to avoid a public backlash. In the next 10–15 years, nanotechnology is likely to revolutionize the practice of medicine and have a significant impact on human health. Nanotechnology is already contributing to the development of new drugs, biologics, and medical devices and the augmentation of existing therapeutics. Over 200 companies are involved in nanomedicine research and development. The U.S. Food and Drug Administration has approved nine different types of therapies that employ nanoscale materials, including products used for medical testing and imaging, drug delivery, wound healing, and bone and tissue repair. Discoveries and innovations in nanomedicine have occurred at a breath taking pace in just a short time, uses of nanotechnology in medicine have moved from laboratory testing, to clinical trials, to medical applications.
- Track 11-1Innovative Practice
- Track 11-2Clinical Research
- Track 11-3Ethical Advancement of Medicine